IgG-producing plasmablasts

Biomarker

1 paper1 finding

  • Human trial1

Interventions

1

Litevax adjuvant

upin humans1

1 study
  1. Litevax adjuvant increases IgG-producing plasmablasts in humans.

    “increased IgG-producing plasmablast frequencies”

    Human trialreceiving a quadrivalent influenza vaccine

    LiteVax-adjuvanted influenza vaccine induces transient interferon-driven innate activation and accelerates early IgG3 responses in older adults

    Research Square3 Aug 2026Preprint

More on Litevax adjuvant

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months